In a seminal review, Baud and Karin listed 11 types of blood-born cancers (including frequent ones such as acute myeloid leukemia (AML)) and 23 solid tumors (including frequent ones such colon cancer), which showed activated NF-κB signaling [26]. This evidence concerns the gene NFKB1 and acute myeloid leukemia.